Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status

BackgroundCOVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status.MethodsThis single-center retrospective study...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinathi Polamraju, Neeta Vachharajani, Brian F. Gage, Jeffrey S. Crippin, William C. Chapman
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Transplantation
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frtra.2024.1515964/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553881298894848
author Vinathi Polamraju
Neeta Vachharajani
Brian F. Gage
Jeffrey S. Crippin
William C. Chapman
author_facet Vinathi Polamraju
Neeta Vachharajani
Brian F. Gage
Jeffrey S. Crippin
William C. Chapman
author_sort Vinathi Polamraju
collection DOAJ
description BackgroundCOVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status.MethodsThis single-center retrospective study identified LT recipients with PCR-confirmed COVID-19 infection from 03/01/2020 to 07/31/2023. Logistic regression analyses were conducted, adjusting for age, race, co-morbidities, number of immunosuppressive agents, and infection date.ResultsOf 1,787 registered LT recipients, 361 had confirmed COVID-19 infection. Of those, 136 were unvaccinated and 225 were vaccinated. 13% had 1 vaccine dose, 31% had 2 vaccine doses, and 56% had 3 vaccine doses prior to infection. Logistic regression found higher mortality (p = 0.001) and hospitalization (p = 0.016) rates for older recipients, while those with 3 or more vaccine doses had lower mortality (p = 0.039) and hospitalization (p = 0.008) rates. Chronic kidney disease (CKD) increased risk of hospitalization (p < 0.001). Adjusting for the date when the Omicron variant became locally predominant, the protective effect from 3 or more vaccine doses declined to an OR (95% CI) of 0.58 (0.15–2.23), p = 0.39.ConclusionsThree or more COVID-19 vaccine doses could decrease mortality for LT recipients, particularly older recipients and those with CKD. These individuals may benefit from vaccination and other interventions.
format Article
id doaj-art-3db0c204a07840958f82ab7a0faa3600
institution Kabale University
issn 2813-2440
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Transplantation
spelling doaj-art-3db0c204a07840958f82ab7a0faa36002025-01-09T06:10:33ZengFrontiers Media S.A.Frontiers in Transplantation2813-24402025-01-01310.3389/frtra.2024.15159641515964Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination statusVinathi Polamraju0Neeta Vachharajani1Brian F. Gage2Jeffrey S. Crippin3William C. Chapman4Department of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesSection of Transplant Surgery, Washington University School of Medicine, St. Louis, MO, United StatesDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United StatesSection of Transplant Surgery, Washington University School of Medicine, St. Louis, MO, United StatesBackgroundCOVID-19 disease burden has been mitigated by vaccination; however, concerns persist regarding weakened immune responses in liver transplant (LT) recipients. This study investigates COVID-19 outcomes in LT recipients based on vaccination status.MethodsThis single-center retrospective study identified LT recipients with PCR-confirmed COVID-19 infection from 03/01/2020 to 07/31/2023. Logistic regression analyses were conducted, adjusting for age, race, co-morbidities, number of immunosuppressive agents, and infection date.ResultsOf 1,787 registered LT recipients, 361 had confirmed COVID-19 infection. Of those, 136 were unvaccinated and 225 were vaccinated. 13% had 1 vaccine dose, 31% had 2 vaccine doses, and 56% had 3 vaccine doses prior to infection. Logistic regression found higher mortality (p = 0.001) and hospitalization (p = 0.016) rates for older recipients, while those with 3 or more vaccine doses had lower mortality (p = 0.039) and hospitalization (p = 0.008) rates. Chronic kidney disease (CKD) increased risk of hospitalization (p < 0.001). Adjusting for the date when the Omicron variant became locally predominant, the protective effect from 3 or more vaccine doses declined to an OR (95% CI) of 0.58 (0.15–2.23), p = 0.39.ConclusionsThree or more COVID-19 vaccine doses could decrease mortality for LT recipients, particularly older recipients and those with CKD. These individuals may benefit from vaccination and other interventions.https://www.frontiersin.org/articles/10.3389/frtra.2024.1515964/fullliver transplantationCOVID-19vaccinationdisease severityrisk factors
spellingShingle Vinathi Polamraju
Neeta Vachharajani
Brian F. Gage
Jeffrey S. Crippin
William C. Chapman
Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
Frontiers in Transplantation
liver transplantation
COVID-19
vaccination
disease severity
risk factors
title Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
title_full Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
title_fullStr Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
title_full_unstemmed Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
title_short Clinical outcomes of COVID-19 infection in liver transplant recipients based on vaccination status
title_sort clinical outcomes of covid 19 infection in liver transplant recipients based on vaccination status
topic liver transplantation
COVID-19
vaccination
disease severity
risk factors
url https://www.frontiersin.org/articles/10.3389/frtra.2024.1515964/full
work_keys_str_mv AT vinathipolamraju clinicaloutcomesofcovid19infectioninlivertransplantrecipientsbasedonvaccinationstatus
AT neetavachharajani clinicaloutcomesofcovid19infectioninlivertransplantrecipientsbasedonvaccinationstatus
AT brianfgage clinicaloutcomesofcovid19infectioninlivertransplantrecipientsbasedonvaccinationstatus
AT jeffreyscrippin clinicaloutcomesofcovid19infectioninlivertransplantrecipientsbasedonvaccinationstatus
AT williamcchapman clinicaloutcomesofcovid19infectioninlivertransplantrecipientsbasedonvaccinationstatus